Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.

Journal of cellular and molecular medicine - 1 May 2020

Hu Qing, Huang Kai, Tao Chuming, Zhu Xingen

Abstract excerpt

Increasing evidence from structural and functional studies has indicated that protein disulphide isomerase (PDI) has a critical role in the proliferation, survival and metastasis of several types of cancer. However, the molecular mechanisms through which PDI contributes to glioma remain unclear. Here, we aimed to investigate whether the differential expression of 17 PDI family members was closely related to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Cluster Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Protein

Share to Disease Progression

Share to Gene Expression Regulation, Enzymologic

Share to Gene Expression Regulation, Neoplastic

Share to Glioma

Share to Protein Disulfide-Isomerases

Source

Open in PubMed Open full text

Identifiers

PMID: 32301283
DOI: 10.1111/jcmm.15264
PMCID: PMC7214159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.PMID 32301283Read ↗

PDIA3 correlates with clinical malignant features and immune signature in human gliomas.Semantic proximity Read ↗

P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.Semantic proximity Read ↗

Emerging roles of protein disulfide isomerase in cancerSemantic proximity Read ↗

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response EffectivelySemantic proximity Read ↗

A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progressionSemantic proximity Read ↗

Assessing the Value of Disulfide Death-Associated Genes in the Prognosis and Treatment of GliomaSemantic proximity Read ↗

Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.Semantic proximity Read ↗

Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in gliomaSemantic proximity Read ↗

PDIA6 promotes glioma malignancy by activating the IRE1α- p-HSP27 signaling axisSemantic proximity Read ↗

Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methodsSemantic proximity Read ↗

Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastomaSemantic proximity Read ↗

Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.